HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pulmonary function of children with right lung middle lobe syndrome].

AbstractOBJECTIVE:
To study the changes of pulmonary function in children with right lung middle lobe syndrome before and after treatment.
METHODS:
Thirty children with right lung middle lobe syndrome were classified into two age groups: < or =4 years old and >4 years old. Pulmonary function was tested by the 2600-type and the MIR-type pulmonary function spirometry in the < or =4 years and the >4 years age groups, respectively before and after treatment. Terminal flows/peak expiratory flow (25/PF) and the percentage of tidal volume to peak tidal expiratory flow (% V-PF) were measured in the <4 years age group. Forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) were measured in the >4 years age group.
RESULTS:
The values of 25/PF and %V-PF in the < or =4 years age group were 0.42+/-0.08 and 0.28+/-0.03, respectively before treatment. The values were improved after treatment (0.58+/-0.12 and 0.39+/-0.06 respectively) (P<0.05). The values of FVC, FEV1 and PEF were 1.75+/-0.32, 1.36+/-0.52 and 2.56+/-0.78, respectively in the >4 years age group before treatment. The values were also improved after treatment (2.37+/-0.78, 2.08+/-0.65 and 3.68+/-0.80 respectively) (P<0.05).
CONCLUSIONS:
There are significant differences in the pulmonary function before and after treatment in children with right lung middle lobe syndrome. The pulmonary function can return to normal after treatment.
AuthorsJian-Jun Huang, Zhi-Jie Tong, Hui-Hong Wen, Jie-Wen Yang, Li-Ping Zhong
JournalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics (Zhongguo Dang Dai Er Ke Za Zhi) Vol. 11 Issue 8 Pg. 669-71 (Aug 2009) ISSN: 1008-8830 [Print] China
PMID19695198 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Child
  • Child, Preschool
  • Female
  • Forced Expiratory Volume
  • Humans
  • Infant
  • Lung (physiopathology)
  • Male
  • Middle Lobe Syndrome (physiopathology)
  • Vital Capacity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: